Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children

ClinicalTrials.gov ID: NCT00764790

Public ClinicalTrials.gov record NCT00764790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity and Safety of GSK Biologicals' Thimerosal-free TIV Flu Vaccine Versus a Licensed Comparator in Children

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the immunogenicity and the safety of GlaxoSmithKline Biologicals' seasonal influenza vaccine, Fluarix, compared to Fluzone (a US-licensed vaccine) in children, 6 to 35 months of age.

Study identification

NCT ID
NCT00764790
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
3,317 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
6 Months to 35 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
Mar 4, 2009
Completion
May 31, 2009
Last update posted
Jul 30, 2018

2008 – 2009

United States locations

U.S. sites
62
U.S. states
27
U.S. cities
61
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35205
GSK Investigational Site Birmingham Alabama 35244
GSK Investigational Site Dothan Alabama 36305
GSK Investigational Site Benton Arkansas 72019
GSK Investigational Site Conway Arkansas 72034
GSK Investigational Site Fayetteville Arkansas 72703
GSK Investigational Site Jonesboro Arkansas 72401
GSK Investigational Site Little Rock Arkansas 72205
GSK Investigational Site Huntington Beach California 92647
GSK Investigational Site Long Beach California 90806
GSK Investigational Site Paramount California 90723
GSK Investigational Site Sacramento California 95816
GSK Investigational Site San Francisco California 94102
GSK Investigational Site West Covina California 91790
GSK Investigational Site Longmont Colorado 80501
GSK Investigational Site Norwich Connecticut 06360
GSK Investigational Site Nampa Idaho 83686
GSK Investigational Site DeKalb Illinois 60115
GSK Investigational Site New Albany Indiana 47150
GSK Investigational Site Arkansas City Kansas 67005
GSK Investigational Site Newton Kansas 67114
GSK Investigational Site Wichita Kansas 67207
GSK Investigational Site Bardstown Kentucky 40004
GSK Investigational Site Louisville Kentucky 40207
GSK Investigational Site Bossier City Louisiana 71111
GSK Investigational Site Metairie Louisiana 70006
GSK Investigational Site Stevensville Michigan 49127
GSK Investigational Site Saint Paul Minnesota 55108
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Omaha Nebraska 68134
GSK Investigational Site Henderson Nevada 89015
GSK Investigational Site Cortland New York 13045
GSK Investigational Site Boone North Carolina 28607
GSK Investigational Site Cary North Carolina 27518
GSK Investigational Site Raleigh North Carolina 27609
GSK Investigational Site Fargo North Dakota 58103
GSK Investigational Site Austintown Ohio 44515
GSK Investigational Site Cincinnati Ohio 45245
GSK Investigational Site Cleveland Ohio 44121
GSK Investigational Site Dayton Ohio 45406
GSK Investigational Site Gresham Oregon 97030
GSK Investigational Site Erie Pennsylvania 16505
GSK Investigational Site Greenville Pennsylvania 16125
GSK Investigational Site Latrobe Pennsylvania 15650
GSK Investigational Site Pittsburgh Pennsylvania 15236
GSK Investigational Site Uniontown Pennsylvania 15401
GSK Investigational Site Wexford Pennsylvania 15090
GSK Investigational Site Charleston South Carolina 29406
GSK Investigational Site Clarksville Tennessee 37043
GSK Investigational Site Jackson Tennessee 38305
GSK Investigational Site Kingsport Tennessee 37660
GSK Investigational Site Austin Texas 78705
GSK Investigational Site Fort Worth Texas 76135
GSK Investigational Site Houston Texas 77055
GSK Investigational Site San Angelo Texas 76904
GSK Investigational Site Bountiful Utah 84010
GSK Investigational Site Layton Utah 84041
GSK Investigational Site Murray Utah 84107
GSK Investigational Site Provo Utah 84604
GSK Investigational Site Roy Utah 84067
GSK Investigational Site South Jordan Utah 84095
GSK Investigational Site Burke Virginia 22015

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00764790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2018 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00764790 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →